Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid

  • J Am Acad Dermatol. 1992 Apr;26(4):535-44. doi: 10.1016/0190-9622(92)70076-r.
R M Lavker  1 ,  K Kaidbey ,  J J Leyden
Affiliations
  • 1. Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia 19104.
PMID: 1597538 DOI: 10.1016/0190-9622(92)70076-r
Abstract

Background: Topical corticosteroids produce atrophic changes in skin, including thinning of the epidermis and decrease in dermal ground substance. We observed that 12% ammonium lactate produced an increase in the thickness of epidermis and increased amounts of dermal glycosaminoglycans.

Objective: Our purpose was to determine whether 12% ammonium lactate could minimize cutaneous atrophy produced by a potent topical corticosteroid.

Methods: Clobetasol propionate, 12% ammonium lactate, and both agents were repetitively applied under occlusive patches as well as in open patches on the forearms of human volunteers for 3 to 4 weeks. Biopsy specimens were analyzed for thickness of the epidermis and dermal glycosaminoglycans by image analysis.

Results: Twelve percent ammonium lactate produced a significant sparing of atrophy in both the epidermis and dermis without any influence on the bioavailability or antiinflammatory properties of the corticosteroid.

Conclusion: Twelve percent ammonium lactate may be useful in mitigating the adverse effects of corticosteroid on skin.

Products